Research output per year
Research output per year
Personal profile
Research interests
- Mechanisms of innate immune cell activation and tissue damage in ocular inflammatory and neovascular conditions.
- Control of immune responses to promote/restore tissue homeostasis and function in the eye.
- In vivo ocular imaging, using Topical Endoscopic Fundal Imaging (TEFI), Fundal Fluorescein Angiography (FA) and Optical Coherence Tomography (OCT) platforms.
- Preclinical testing of novel therapeutic approaches using ocular disease models.
Fingerprint
Dive into the research topics where David A Copland is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Can NRF2 provide a gene-agnostic approach to treating age-related macular degeneration?
Clare, A. J., Dick, A. D., Copland, D. A., Liu, J. & Chan, K., 3 Jun 2026, In: Molecular Therapy. 34, 6, p. 3142-3144 3 p.Research output: Contribution to journal › Comment/debate (Academic Journal)
-
Microglia-independent rAAV-induced inflammation causes persistent ocular immune dysregulation rescued by S1P receptor modulation
Langer, P. M., Clare, A. J., Peng, X., Costello, K. L., Cendanawati, S., Wilson, L. L., Ward, A., Bell, O. H., Chu, C. J., Chan, Y. K., Dick, A. D., Pepple, K. L. & Copland, D. A., 6 May 2026, In: Molecular Therapy. 34, 5, p. 2840-2862 23 p.Research output: Contribution to journal › Article (Academic Journal) › peer-review
Open Access -
The Immunopathogenesis of uveitis
Han, J., Harper, J., Copland, D. A. & Maghsoudlou, P., 2 Mar 2026, In: Frontiers in Medicine. 13, 23 p., 1717056.Research output: Contribution to journal › Review article (Academic Journal) › peer-review
Open Access6 Citations (Scopus)
-
8542 A novel dual-target gene therapy for safe and efficacious treatment of chronic non-infectious uveitis
Copland, D. A. (Principal Investigator)
1/06/24 → 31/12/26
Project: Research
-
A novel dual-target gene therapy for safe and efficacious treatment of chronic non-infectious uveitis
Copland, D. A. (Principal Investigator)
1/06/24 → 31/05/26
Project: Research, Parent
-
A novel dual-target gene therapy for safe and efficacious treatment of chronic non-infectious uveitis
Copland, D. A. (Principal Investigator)
1/06/24 → 31/05/26
Project: Research